Viewing Study NCT03822468


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-25 @ 3:06 PM
Study NCT ID: NCT03822468
Status: COMPLETED
Last Update Posted: 2025-10-16
First Post: 2019-01-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: